Vsee Health, Inc. (VSEEW) — SEC Filings
Vsee Health, Inc. (VSEEW) — 50 SEC filings. Latest: S-1 (Dec 29, 2025). Includes 35 8-K, 4 10-Q, 2 S-1.
View Vsee Health, Inc. on SEC EDGAR
Overview
Vsee Health, Inc. (VSEEW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a S-1 filed on Dec 29, 2025: VSee Health, Inc. (VSEEW) filed an S-1 on December 29, 2025, primarily for the resale of up to 33,808,195 shares of common stock by selling stockholders, rather than a primary offering by the company. The filing details several private placement transactions that occurred in late 2025, including the
Sentiment Summary
Across 50 filings, the sentiment breakdown is: 12 bearish, 37 neutral, 1 mixed. The dominant filing sentiment for Vsee Health, Inc. is neutral.
Filing Type Overview
Vsee Health, Inc. (VSEEW) has filed 2 S-1, 35 8-K, 1 8-K/A, 1 DEF 14A, 1 10-Q/A, 4 10-Q, 1 10-K/A, 1 10-K, 2 S-1/A, 2 SC 13G/A with the SEC between Sep 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (50)
Risk Profile
Risk Assessment: Of VSEEW's 44 recent filings, 13 were flagged as high-risk, 17 as medium-risk, and 14 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $10,692,259 |
| Net Income | $(6,862,468) |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $472,759 |
| Operating Margin | N/A |
| Total Assets | $18,707,122 |
| Total Debt | $24,282,620 |
Key Executives
- Dr. Milton Chen
- M. Ali Panjwani, Esq.
- Dr. Imoigele Aisiku
- Jerry Leonard
- Kevin Lowdermilk
- Colin O'Sullivan
- Dr. Scott Metzger
- Cydonii V. Fairfax
- Imoigele Aisiku
- Milton Chen
Industry Context
VSEE HEALTH, INC. operates within the health technology sector, which is characterized by rapid innovation, increasing demand for telehealth and remote patient monitoring solutions, and a competitive landscape with both established players and emerging startups. The industry is driven by technological advancements, regulatory changes, and evolving consumer preferences for convenient and accessible healthcare services.
Top Tags
exhibits (7) · financial-statements (7) · delisting (7) · Telehealth (6) · material-agreement (6) · listing-standards (6) · filing (5) · financials (5) · Going Concern (5) · 8-K (5)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Total shares registered for resale | 33,808,195 | Represents potential significant dilution for existing stockholders. |
| Manatt Shares | 3,000,000 | Common Stock held by Manatt, Phelps & Phillips, LLP. |
| Series B Shares | 1,300,000 | Shares issuable to Manatt upon conversion of Series B Preferred Stock. |
| Armistice Pre-Funded Warrant Shares | 9,836,065 | Shares issuable to Armistice upon exercise of pre-funded warrants. |
| Armistice Warrant Shares | 19,672,130 | Shares issuable to Armistice upon exercise of common warrants. |
| Manatt Debt | $2,132,000 | Approximate amount of unpaid legal fees settled with equity in the Manatt Private Placement. |
| Common Stock Price | $0.405 | Last reported sale price on Nasdaq on December 26, 2025. |
| Public Warrant Price | $0.0801 | Last reported sale price on Nasdaq on December 26, 2025. |
| Armistice Private Placement Closing Date | December 1, 2025 | Date of the private placement with Armistice Capital Master Fund Ltd. |
| Manatt Private Placement Closing Date | December 9, 2025 | Date of the private placement with Manatt, Phelps & Phillips, LLP. |
| Class I directors to be elected | 2 | Dr. Milton Chen and Dr. Imoigele Aisiku are up for re-election until 2028 |
| Annual Meeting Date and Time | 2025-12-15T14:30:00.000Z | Stockholders will vote on proposals at 2:30 P.M. Eastern Time |
| Record Date | 2025-11-20T00:00:00.000Z | Holders of record on this date are entitled to vote |
| Shares of Common Stock outstanding | 32,289,750 | Total votes from Common Stock as of the Record Date |
| Shares of Preferred Stock outstanding | 1,788 | Entitled to 178,800 votes as of the Record Date |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Vsee Health, Inc. (VSEEW)?
Vsee Health, Inc. has 50 recent SEC filings from Sep 2024 to Dec 2025, including 35 8-K, 4 10-Q, 2 S-1. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of VSEEW filings?
Across 50 filings, the sentiment breakdown is: 12 bearish, 37 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Vsee Health, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Vsee Health, Inc. (VSEEW) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Vsee Health, Inc.?
Key financial highlights from Vsee Health, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for VSEEW?
The investment thesis for VSEEW includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Vsee Health, Inc.?
Key executives identified across Vsee Health, Inc.'s filings include Dr. Milton Chen, M. Ali Panjwani, Esq., Dr. Imoigele Aisiku, Jerry Leonard, Kevin Lowdermilk and 5 others.
What are the main risk factors for Vsee Health, Inc. stock?
Of VSEEW's 44 assessed filings, 13 were flagged high-risk, 17 medium-risk, and 14 low-risk.
What are recent predictions and forward guidance from Vsee Health, Inc.?
Forward guidance and predictions for Vsee Health, Inc. are extracted from SEC filings as they are enriched.